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A hyaluronidase (CdtHya1) from Crotalus durissus terriﬁcus snake venom (CdtV) was isolated and showed
to exhibit a high activity on hyaluronan cleavage. However, surveys on this enzyme are still limited. This
study aimed at its isolation, functional/structural characterization and the evaluation of its effect on the
spreading of crotoxin and phospholipase A2 (PLA2). The enzyme was puriﬁed through cation exchange,
gel ﬁltration and hydrophobic chromatography. After that, it was submitted to a reverse-phase fast
protein liquid chromatography (RP-FPLC) and Edman degradation sequencing, which showed the ﬁrst N-
terminal 44 amino acid residues whose sequence evidenced identity with other snake venom hyal-
uronidases. CdtHya1 is a monomeric glycoprotein of 64.5 kDa estimated by SDS-PAGE under reducing
conditions. It exhibited maximum activity in the presence of 0.2 M NaCl, at 37 C, pH 5.5 and a speciﬁcity
to hyaluronan higher than that to chondroitin-4-sulphate, chondroitin-6-sulphate or dermatan. Divalent
cations (Ca2þ and Mg2þ) and 1 M NaCl signiﬁcantly reduced the enzyme activity. The speciﬁc activity of
CdtHya1 was 5066 turbidity reducing units (TRU)/mg, against 145 TRU/mg for the soluble venom, rep-
resenting a 34.9-fold puriﬁcation. The pure enzyme increased the diffusion of crotoxin and PLA2 through
mice tissues. CdtHya1 (32 TRU/40 mL) potentiated crotoxin action, as evidenced by mice death, and it
decreased the oedema caused by subplantar injections of buffer, crotoxin or PLA2, thus evidencing the
relevance of hyaluronidase in the crotalic envenoming. This work yielded a highly active anti-
edematogenic hyaluronidase from CdtV, the ﬁrst one isolated from rattlesnake venoms.
 2012 Elsevier Masson SAS. Open access under the Elsevier OA license.1. Introduction
Snakebites related to the genus Crotalus are responsible for the
highest levels of mortality described for ophidian accidents in
Brazil [1]. Crotalus durissus terriﬁcus venom (CdtV) shows neuro-
toxic, myotoxic and coagulant properties [2], being the acute renal
dysfunction the most serious complication of Crotalus snake bite
[3]. Induction of systemic effects depends upon the toxins
concentration and on their diffusion rate into the blood circulation
to reach their site(s) of action [4]. Local tissue damage is also
induced and is one of the most dramatic characteristics of viperid
envenoming [5], including necrosis, haemorrhage, oedema and
extracellular matrix degradation [5,6]. Since these problems reﬂect
body spreading of venom toxins, the aim of this study was theQuímica, Faculdade de Ciên-
e São Paulo, Av. do Café s/n,
4275; fax: þ55 16 3633 2960.
s).
nder the Elsevier OA license.isolation, functional and structural characterization of a hyaluroni-
dase from CdtV.
Hyaluronidases (E.C. 3.2.1.35) have been reported as a constant
component from snake venoms [4,7]. These enzymes are known as
“spreading factors” [4,8] because they cleave hyaluronan, a non-
proteoglycan polysaccharide found in the extracellular matrix
(ECM), facilitating toxin diffusion into the tissues and blood circula-
tion of the prey/victims [8e11]. Although they are not toxins [4,10],
they indirectly potentiate the toxicity of venoms [4,8], contributing to
local and systemic envenoming [11] and to the local tissue wrecking
[12]. Furthermore, the envenomed victim may have a systemic
collapse if circulatinghyaluronan isdegraded in thebloodstream[12].
Their speciﬁc activities are quite variable among different
species, even among those belonging to the same snake genus
[11,13]. A comparative study of the hyaluronidase activity of
rattlesnake venoms showed that venom samples of Crotalus hor-
ridus horridus, Crotalus horridus atricaudatus, C. d. terriﬁcus and
Crotalus viridis viridis display very high hyaluronidase activity,
while Crotalus ruber ruber and Sistrurus miliarius barbouri venom
samples exhibited only trace amounts of this activity [14].
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by monoclonal antibodies or some plant extracts inhibited tissue
damage, the diffusion and the lethal effects of ophidian venoms
[9,15e17]. Hyaluronidase inhibitors may be proteins, glycosami-
noglycans, polysaccharides, fatty acids, lanostanoids, antibiotics,
anti-nematodes, synthetic organic compounds, alkaloids, antioxi-
dants, polyphenols, ﬂavonoids, terpenoids or anti-inﬂammatory
drugs [18]. It is probable that hyaluronidase inhibition would
improve antivenom therapy by retarding toxins diffusion. In addi-
tion, the side effects of this therapy would be extenuated, since
a lower dose would be effective for venom neutralization [19].
Furthermore, hyaluronidase has been used in various off-label
clinical conditions to reduce tissue oedema, such as paraphimosis
[20], supraglottic airway oedema [21] and diabetic macular oedema
[22], as well as to facilitate reduction of intestinal intussusception
[23] and after organ transplantation [24].
However, in spite of the important role in ophidism, these
enzymes have been practically ignored, as evidenced by the
reduced number of published studies. Although there are about
400 venomous snakes known in the world among more than 3000
snake species (http://www.reptile-database.org) and hyaluroni-
dases are ubiquitous in snake venoms [4,7], there are only a few
studies on ophidian hyaluronidases isolated from Agkistrodon
acutus [10], Agkistrodon contortrix contortrix [13], Naja naja [4],
Agkistrodon blomhofﬁi ussurensis [25] and Daboia russelli [26]
venoms.
Given the limited information regarding hyaluronidases and the
important role of these enzymes for understanding the mechanism
of action of snake venoms, this study aimed at the isolation, func-
tional and structural characterization of the enzyme from CdtV and
the evaluation of its role as a spreading factor of crotoxin and PLA2.
Our study is the ﬁrst one to isolate and characterize a rattlesnake
hyaluronidase. The functional and structural characterization of
CdtHya1 presented here may contribute to the optimization of
therapies for ophidian accidents, and help in the understanding of
the numerous pathophysiological processes inwhich the enzyme is
involved. In this study, the effect of CdtHya1 on the edematogenic
activity induced by crotoxin and PLA2 isolated from CdtV was also
investigated, since these toxins can induce or exacerbate inﬂam-
matory response [27], producing paw oedema in rodent models
[28].
2. Material and methods
2.1. Material
Desiccated CdtV and male Swiss mice (28e32 g) were provided
by Biotério Central (Universidade de São Paulo, Ribeirão Preto, SP,
Brazil), in accordance with the guidelines of the Brazilian College
for Animal Experimentation (COBEA) and Ibama, Brazilian Institute
of Environment. Animal use was approved by the Committee for
Ethics in Animals Utilization of Universidade de São Paulo (n
08.1.1038.53.1). Hyaluronan, chondroitin-4-sulphate, chondroitin-
6-sulphate and dermatanwere purchased from Sigma Chemical Co.
(St. Louis, USA). CM-cellulose resin and HiPrep Sephacryl S-100 and
HiTrap Phenyl-Sepharose columns were purchased from GE
(Uppsala, Sweden). All other reagents usedwere of analytical grade.
2.2. Isolation of CdtHya1
Desiccated CdtV (1 g) was suspended in 50 mL of 0.05 M sodium
acetate buffer, pH 5.5, centrifuged at 15,700 g, 4 C, for 10min, and
applied on a CM-cellulose-52 column (1  40 cm). Fractions were
eluted using a step concentration gradient from 0 to 1.0 M NaCl in
the same buffer, at a ﬂow rate of 0.5 mL/min. Fractions of 2.0 mL/tube were collected at 25 C. The sixth fraction, named CM6, was
concentrated through a 30 kDa membrane on a model 8010 stirred
ultraﬁltration cell (Millipore Corp, Billerica, USA) and then ﬁltered
on a HiPrep Sephacryl S-100 (1.6  60 cm) column previously
equilibrated with 0.05 M sodium acetate buffer containing 0.15 M
NaCl, pH 5.5. The second fraction, named S2, was applied to aHiTrap
Phenyl-Sepharose column (1 mL, GE, Uppsala, Sweden) and the pure
CdtHya1 was eluted using a linear concentration gradient from 1.0
to 0 M NaCl in a 0.05 M sodium acetate buffer, pH 5.5. Purity of the
isolated hyaluronidase CdtHya1 was conﬁrmed by reverse phase
FPLC using a Shodex C4 column (0.46  25 cm, Showa Denko KK,
Kawasaki, Japan), eluting with a step concentration gradient from
0 to 100% of solvent B (60% acetonitrile, 0.1% triﬂuoroacetic acid), at
a ﬂow rate of 1.0 mL/min at room temperature. Absorbances
(l ¼ 280 nm) were registered by FPLC Äkta Puriﬁer UPC-10 system
(GE, Uppsala, Sweden).
2.3. Hyaluronidase assay
Hyaluronidase activity was performed by a turbidimetric assay
[11] adapted to microplate, with a 5-fold reduction of all reagents.
To determine the optima conditions for hyaluronidase activity,
venom and hyaluronan were incubated for 15 min at several pHs
(2e11) and temperatures (0e80 C). Sodium acetate buffers (0.2 M)
containing different concentrations of NaCl (0e1 M) or 0.2 M
different salts (NaCl, KCl, CaCl2 and MgCl2) were employed to
determine ion effects on the enzyme activity. The assay conditions
producing maximum hyaluronidase activity were chosen for
subsequent experiments. Turbidity reducing units (TRU) are
expressed as the amount of enzyme required to hydrolyze 50%
(5 mg) of hyaluronan; speciﬁc activity is turbidity-reducing units
per mg of enzyme. Pessini et al. [29] determined that 0.153 TRU
corresponds to 1 NFU (National Formulary Unit) according to Poh
et al. [30]. Hyaluronidase activity on 0.5 mg/mL of different
substrates (hyaluronan, chondroitin-4-sulphate, dermatan or
chondroitin-6-sulphate) was evaluated under optimal conditions.
2.4. Kinetic studies
Kinetic studies were performed according to Poh et al. [30].
CdtHya1 (0.07 mg/mL) was incubated in 15 min under optima
conditions with hyaluronan (5.4e432 mg/mL) or chondroitin-4-
sulphate, chondroitin-6-sulphate or dermatan (5e50 mg/mL). The
velocity of the reaction was expressed as micrograms of substrate
hydrolyzed per millilitre per minute. Km and Vmax were
determined by Prisma 6.0 software (GraphPad Software Inc., San
Diego, USA).
2.5. Determination of proteins
Determination of total proteins was carried out according to the
method described by Bradford [31], using Bio-Rad Protein assay
(Bio-Rad Laboratories, Inc., Berkeley, USA) and conﬁrmed by 280/
205 nm absorption method [32]. Bovine serum albumin (BSA) was
used as standard.
2.6. SDS-PAGE
SDS-PAGE (10%) containing hyaluronan was run. After electro-
phoresis, part of the gel was stainedwith Stains-all (Sigma Chemical
Co., St. Louis, USA) for evaluation of the hyaluronidase activity [33],
and the remaining with PlusOne Coomassie Blue PhastGel R-350
(GE Healthcare, Uppsala, Sweden). SDS-PAGE (10%) was carried out
according to Laemmli [34]; after that, periodic acid-Schiff (PAS)
staining was used to detect glycoproteins [35].
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The sequence of hyaluronidase CdtHya1 was determined by
Edman degradation [36], performed on an automated sequenator
model PPSQ-33A (Shimadzu Co., Kyoto, Japan). The identity of thus
primary sequence compared with those of other proteins was
searched by using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
The amino acid sequences of snake venom hyaluronidases were
retrieved from the Universal Protein Resource Knowledgebase
(www.uniprot.org). The alignment was created by MultAlin
Interface Page [37] and the ﬁgure was generated by ESPript [38]
server.
2.8. Paw oedema
Paw oedema was induced in male Swiss mice (28e32 g) by
subplantar injection of buffer containing crotoxin or PLA2 with or
without hyaluronidase CdtHya1, in the right hind paw. The volume
of the paw was measured with a paquimeter (Mitutoyo, Kawasaki,
Japan) before and after toxin injections at different intervals of time
(n ¼ 5). The data (mean  standard error of the mean) were
analyzed by one-way ANOVA followed by Tukey’s test (p< 0.05was
considered statistically signiﬁcant).
3. Results
3.1. Isolation of CdtHya1
CdtHya1 was puriﬁed by three chromatographic steps: cation
exchange, gel ﬁltration and hydrophobic chromatography.Fig. 1. Isolation of CdtHya1. Absorbance was monitored at 280 nm, at 25 C, using a FPLC Ä
vertical bars indicate the percentage of hydrolyzed hyaluronan (hyaluronidase activity). (A
CdtV (1 g) was dispersed in 50 mL 0.05 M sodium acetate buffer, pH 5.5 and, after the centri
equilibrated with 0.05 mol/L sodium acetate buffer, pH 5.5. Adsorbed proteins were eluted u
containing 1 M NaCl, pH 5.5). Fractions of 2.0 mL/tube were collected at a ﬂow rate of 0.
(1.6  60 cm) equilibrated and eluted with 0.05 M sodium acetate buffer containing 0.15 M
Hydrophobic chromatography of fraction S2 on HiTrap Phenyl-Sepharose column (two 1 m
buffer, pH 5.5, containing 1 M NaCl, pH 5.5). Adsorbed proteins were eluted with a linear con
1.0 mL/tube were collected at a ﬂow rate of 1.0 mL/min. (D) Reverse-phase FPLC of CdtHya1 o
(TFA). Adsorbed proteins were eluted using a concentration gradient from 0 to 100% of soluti
of 0.8 mL/min.The crude soluble venom of C. d. terriﬁcus, when applied on
a CM-cellulose-52 column, showed nine fractions, named “CM1” to
“CM9” (Fig. 1A). Hyaluronidase activity was detected in fractions
“CM5” and “CM6” (vertical bars, Fig. 1A). In this study, only fraction
“CM6” was used, because it has shown higher hyaluronidase
activity. Around 12.4% of the total activity was recovered, from
which 0.99% in fraction “CM6”. This fraction was subjected to
a Sephacryl S-100 molecular sieve chromatography and four sub-
fractions were obtained. Hyaluronidase was detected in fraction S2
(Fig. 1B). Pure hyaluronidase was isolated by rechromatographing
fraction S2 on a Phenyl-Sepharose column and it was named
CdtHya1 (Fig. 1C). It has a speciﬁc activity 34.9 times higher than
that of the crude soluble venom and represents 8.2% of the total
activity and 0.23% of the total protein (Table 1). Afterwards, the
purity degree of CdtHya1 was checked by reverse-phase FPLC on
a C4 column, disclosing a single peak (Fig. 1D).
3.2. Hyaluronidase activity and kinetic assays
Reducing SDS-PAGE indicated that CdtHya1 presents a single
band of about 64.5 kDa. Under non-reducing conditions, it shows
a single polypeptide chain of about 74.1 kDa which corresponds to
the translucent band against the dark blue background in the gel
with hyaluronan (Fig. 2A). The enzyme is a glycoprotein, as evi-
denced by PAS staining (Fig. 2B, lane 4).
CdtHya1 is active within the pH range from 4 to 7, with an
optimum pH of 5.5 (Fig. 3A). It is active between 10 and 50 C with
optimal activity at 37 C (Fig. 3B). The enzyme was stable for 30
days in the puriﬁcation buffer at 7 C and still active for more than
60 days under the same conditions. Hyaluronidase was isolatedkta Puriﬁer UPC-10 system. The dotted lines represent the concentration gradient. The
) Cation-exchange chromatography of crude soluble Crotalus durissus terriﬁcus venom.
fugation, the supernatant was fractionated on a CM-cellulose-52 column (1.0  40 cm)
sing a concentration gradient from 0 to 100% of buffer B (0.05 M sodium acetate buffer
5 mL/min. (B) Gel ﬁltration of fraction CM6 on a HiPrep Sephacryl S-100 HR column
NaCl, pH 5.5. Fractions of 1.2 mL/tube were collected at a ﬂow rate of 0.5 mL/min. (C)
L columns connected in series) equilibrated with buffer B (0.05 mol/L sodium acetate
centration gradient from 100 to 0% of buffer B (same buffer without NaCl). Fractions of
n a C4 column (0.46  25 cm, 5 mm particles) equilibrated with 0.1% triﬂuoroacetic acid
on B (60% acetonitrile in 0.1% TFA). Fractions of 1.0 mL/tube were collected at a ﬂow rate
Table 1
Recovery and speciﬁc activity of chromatographic components obtained during the puriﬁcation procedure of hyaluronidase from Crotalus durissus terriﬁcus snake venom.
Fraction Puriﬁcation step Total proteina (mg) Protein recovery (%) Total activity (TRU)b Yield (%) Speciﬁc activity (TRU/mg) Relative activity
CdtV Supernatant 556.0 100.0 80,697 100.0 145 1.0
CM6 CM-cellulose-52 5.5 0.99 10,000 12.4 1805 12.4
S2 Sephacryl S100 2.5 0.45 5198 6.4 2079 14.3
CdtHya1 Phenyl-Sepharose 1.3 0.23 6586 8.2 5066 34.9
a Total protein quantiﬁed by absorbance method 280/205 nm (SCOPES, 1974).
b Turbidity reducing units: amount of protein required to hydrolyze 50% (5 mg) of hyaluronan after 15 min of incubation at 37 C.
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greatly inﬂuenced by sodium chloride. At concentrations above
0.3 M, NaCl can induce a false positive hyaluronidase activity
(control data not shown) and maximum activity is observed in the
presence of 0.2 M NaCl (Fig. 3C). Divalent cations (Ca2þ and Mg2þ)
and 1MNaCl signiﬁcantly reduced the enzyme activity (Fig. 3D and
C, respectively). Furthermore, CdtHya1 exhibited higher activity on
hyaluronan than on chondroitin-4-sulphate, chondroitin-6-
sulphate or dermatan (Fig. 3E).
It was observed by Kcat that CdtHya1 hydrolyzes about 10 times
more hyaluronan than chondroitin-4-sulphate, chondroitin-6-
sulphate or dermatan (Table 2). However, CdtHya1 shows from
5.3 to 6.9 times higher afﬁnity to these three later substrates than to
hyaluronan, as evidenced by Km. Afterwards, the enzyme presents
a catalytic efﬁciency about 1.7 times greater to hydrolyze hyalur-
onan than to cleavage chondroitin-4-sulphate, chondroitin-6-
sulphate or dermatan and its catalytic efﬁciency is the same for
these three later tested substrates (Table 2).
3.3. Antiedematogenic activity
Oedema peak reached a maximum at 30 min for almost all the
injected solutions (Fig. 4). Crotoxin and PLA2 groups induced
a signiﬁcant increase in the volume of the paw of the animal when
compared to control (p < 0.001). The association of pure hyal-
uronidase to PLA2 caused a delay in the time of maximum oedema
peak and reduction of the oedema induced by PLA2, crotoxin or
buffer. The reduction of oedema caused by hyaluronidase dissolved
in buffer was signiﬁcant (p < 0.01) after 30 min, when compared to
the control. At 340 min, it was observed a signiﬁcant oedema only
in the groups crotoxin and crotoxin þ hyaluronidase (p < 0.01).
3.4. Initial N-terminal and in silico studies
The ﬁrst 44 N-terminal amino acids from CdtHya1 were deter-
mined as MQAKAPMYPNEPFLVFWNAPTTQCRLRYKVDLDLNTFHIV-Fig. 2. SDS-PAGE (10%). (A) Gel containing hyaluronan. The gel was stained with
Coomassie Blue R-350 (lanes 1e5) and with Stains-all for evaluation of the hyal-
uronidase activity (lanes 6e7). Lanes 1 and 7: CdtV (34 mg); 2: CM6 (11 mg); 3 and 6:
non-reduced CdtHya1 (5 mg); 4: MW standards (GE Healthcare, 17-0446-01); 5:
reduced CdtHya1 (5 mg). (B) Periodic acid-Schiff (PAS) staining was used to detect
glycoprotein.1: CM6; 2: MW standards (GE Healthcare, 17-0615-01); 3: S2; 4: CdtHya1.TNAR. This primary sequence will appear in the UniProt Knowl-
edgebase under the accession number B3EWP2 and showed iden-
tity with other hyaluronidases sequences deposited in data banks
(Fig. 5).
Residue Glu135, which participates in the catalytic mechanism,
is conserved in the sequences of the aligned snake hyaluronidases.
Residues Asp133, Tyr206, Tyr253 and Trp328 are essential for the
positioning of the substrate’s carbonyl of the acetamido group for
catalysis and are conserved among vertebrate hyaluronidases [39].
The cysteine scaffold is also conserved among these sequences
hyaluronidases: Cys47, Cys340, Cys211, Cys227, Cys365, Cys370,
Cys376 and Cys429 [12].
4. Discussion
The puriﬁcation procedure of the hyaluronidase from CdtV by
three chromatographic steps (protein recovery¼ 0.23%) was able to
provide a highly active enzyme. SDS-PAGE under reducing and non-
reducing conditions, reversed phase FPLC and N-terminal
sequencing analysis conﬁrmed the high degree of purity of the
enzyme. The speciﬁc activity for the soluble venom was 145
turbidity reducing units (TRU)/mg against 5066 TRU/mg for pure
hyaluronidase, representing a 34.9-fold puriﬁcation.
Hyaluronidase CdtHya1 is a monomeric glycoprotein of
64.5 kDa, as estimated by SDS-PAGE under reducing conditions.
Most venom hyaluronidases related in earlier reports are mono-
meric proteins [10,11,26,29,40e42]. The observed molar mass is
within the range of 50e70 kDa described for hyaluronidases from
viperid and elapid snake venoms [4,12,13,33].
CdtHya1 showed a maximum activity at pH 5.5 and its activity
decreased by half at pH 6.5 and it was virtually abolished at pH 7.0.
Hyaluronidases from snake, bee, scorpion and lizard venoms are
optimally active in vitro in a pH range from 4.0 to 6.0
[4,8,10,13,26,29,30,41,43]. Generally, hyaluronidases are classiﬁed
as acid active (active between pH 3 and 4) or neutral active (active
between pH 5 and 6) [44,45]. Being optimally active at pH 5.5,
CdtHya1 belongs to the later class. Interestingly, several compo-
nents of snake venoms induce the releasing of mediators which
promote local inﬂammation [46e48] and the inﬂammatory
exudates generated cause decrease in pH, usually between 6.9 and
6.0 [49]. In addition, many snake bites are to the skin and subcu-
taneous tissue [48], where pH is slightly acidic [50]. At these acidic
conditions, hyaluronidase activity is maximal, thus occurring the
local tissue injury and systemic distribution of venom components
by the enzyme.
CdtHya1 exhibited a maximal activity at 37 C and it was
completely denatured above 60 C. Other snake venom hyaluron-
idases lose their native conformation by heating at 60 C [4,13,51].
Hyaluronidases show considerable variation in thermal stability.
Some preparations rapidly lose their activity when stored above
4 C [8] while others are stable and maintain the enzyme activity at
room temperature for several days [52]. Hyaluronidase from Vipera
russelli siamensis venom lost 15% of activity after 2 weeks storage in
a solution at 4 C [11] and the enzyme from N. naja remained stable
for over 15 days at 37 C [4]. In this work it was detected about 60%
Fig. 3. Determination of hyaluronidase activity of CdtHya1 from Crotalus durissus terriﬁcus venom using a turbidimetric assay (as described in item 2.3 of Material and methods). (A)
pH-proﬁle. (B) Temperature-proﬁle. (C) Effect of NaCl concentration. (D) Effect of 0.2 M different salts (NaCl, KCl, CaCl2 or MgCl2). (E) Activity of CdtHya1 on different substrates
(hyaluronan, chondroitin-4-sulphate (C4S), dermatan or chondroitin-6-sulphate (C6S)) under optimal conditions.
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60 days at 20 C and it was active after storage for several months
at 4 C, although degradation bands by SDS-PAGE (data not shown)
have been detected.
Although CdtHya1 has partially degraded chondroitin-4-
sulphate, chondroitin-6-sulphate and dermatan, its higherTable 2
Kinetic parameters of substrate hydrolysis by hyaluronidase CdtHya1 from Crotalus
durissus terriﬁcus snake venom.
Parameters Hyaluronan C4S Dermatan C6S
Kcat (min1)a 3781.0 410.6 361.3 317.5
Km (mg mL1)b 164.5 31.0 26.7 23.9
Kcat/Km (mg1 mL min1)b 23.0 13.3 13.5 13.3
A kinetic study was carried out using 5.4e432 mg/mL hyaluronan or 5e50 mg/mL
chondroitin-4-sulphate (C4S), chondroitin-6-sulphate (C6S), or dermatan as
substrates. After 15 min of incubation at 37 C, the amounts of hydrolyzed substrate
were determined by a turbidimetric assay. Data were obtained from one repre-
sentative experiment. Kinetic constants were calculated by ﬁtting the data to the
MichaeliseMenten equation using a non-linear regression in Prism (GraphPad
Software).
a Kcat ¼ Vmax/[E], relates the maximum velocity (Vmax) to the total active site
concentration [E]; Kcat is the catalytic constant or the turnover number of an
enzyme.
b Kcat/Km, corresponds to the catalytic efﬁciency of the enzyme; Km is the
concentration of substrate corresponding to ½ Vmax.
Fig. 4. Edematogenic effect of samples dissolved in 40 mL of 50 mM sodium acetate
buffer, pH 5.5: control (losanges), 4 mg crotoxin (squares), 4 mg PLA2 (up triangles), 32
TRU CdtHya1 (down triangles), 4 mg crotoxin þ 32 TRU CdtHya1 (closed circles), 4 mg
PLA2 þ 32 TRU CdtHya1 (open circles). The solutions were injected into the subplantar
surface of the right hind paw of male Swiss mice (28e32 g). Oedema was determined
by the percentage of increased paw thickness (mm) at 30, 60, 120, 180, 240 and
330 min. Each point represents the mean  S.E.M. (n ¼ 5) at each time. **p < 0.001 and
*p < 0.01 compared to the respective control (one-way ANOVA, followed by Tukey’s
test).
Fig. 5. Sequence alignments of the initial N-terminal of: CdtHya1 (bottom) and hyaluronidases from four species of snakes: Bitis arietans (UniProt ID A3QVN9), Echis pyramidum
leakeyi (UniProt ID A3QVN6), Cerastes cerastes cerastes (UniProt ID A3QVN3) and Echis ocellatus (UniProt ID A3QVN2). The conserved residues are in black, and those highly
conserved in CdtHya1 are highlighted in black. The amino acid residues in red indicate low consensus. Cys residues are shaded blue (+). Residue Glu highlighted in pink (B)
participates in the catalytic mechanism. The residues highlighted in green are essential for the positioning of the carbonyl of the acetamido group of the substrate for catalysis (C).
Residue Tyr highlighted in purple (-) is responsible for speciﬁcity for hyaluronan. Asn-aaX-Ser/Thr residues highlighted in yellow (:) represent the possible N-glycosylation sites
predicted by NetNGlyc 1.0 Server. Alignment and ﬁgure were generated by MultAlin (CORPET, 1988) and ESPript (GOUET et al., 1999) servers, respectively. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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sented the lowest afﬁnity (higher Km) and the highest hydrolysis
rate on hyaluronan, when compared on chondroitin-4-sulphate,
chondroitin-6-sulphate or dermatan. It is speculated that this
outstanding result is due to differences in polymer sizes and
isomeric patterns. Hyaluronan has a molar mass between 3  106
and 5.8  106, while the other tested substrates have a molar mass
in the range of 1  104e4  104 (Sigma’s technical information).
Since hyaluronan is far greater than the other substrates, it presents
a higher number of repeating units of N-acetyl-D-glucosamine and
D-glucuronic acid to be cleaved, thus facilitating the access of
hyaluronidase to the hydrolysis sites. Another difference is that
hyaluronan is formed by N-acetyl-D-glucosamine, while the other
tested substrates are formed by N-acetyl-D-galactosamine-
sulphate. Snake venom hyaluronidases (EC 3.2.1.35) degrade hya-
luronan, chondroitin, chondroitin-4-sulphate and chondroitin-6-
sulphate, producing mainly tetrasaccharides [53]. In contrast,
hyaluronidases from N. naja [4] and A. c. contortrix [13] venoms
exhibited absolute speciﬁcity to hyaluronan whereas bovine
testicular hyaluronidase cleaved various glycosaminoglycans
tested, including hyaluronan, chondroitin, chondroitin-4-sulphate,
chondroitin-6-sulphate, chondroitin sulphate D and chitosans of
high, medium and low molar mass [4].
The turbidimetric method for hyaluronidase assay is very
dependent upon salt concentration [54,55]. So it is necessary to
establish conditions of salt concentration under which such assays
can be carried out with the least possible interference from salt
effects [56,57]. Regarding negative control, as salt concentration
increases, there is a marked drop in turbidity. These values should
be discounted from those regarding the active fractions eluted with
a concentration gradient of NaCl (0e1 M) in the chromatographic
steps to avoid a false positive activity. Maximum hydrolysis was
achieved with 0.2 M NaCl. Up to 0.3 M, there is little interference of
NaCl in the reduction of the turbidity of hyaluronan and the activity
is abolished with 1 M NaCl. Further experiments were carried out
using other 0.2 M salts. Naþ and Kþ, enhanced the hyaluronidase
activity while divalent cations, Mg2þ and Ca2þ, inhibited the
enzyme activity. Similar results were observed for hyaluronidase
from funnel web spider in the presence of 0.3 M salts, when
monovalent cations enhanced the activity and divalent cationswere
found to be inhibitory [56]. Hyaluronidase from A. c. contortrix also
showed maximum activity in the presence of 0.2 M NaCl [13]. The
hyaluronidase activity from N. najawas maximal in the presence of
0.15 M NaCl and inhibited at concentrations above 0.5 M NaCl [4].
Pure CdtHya1 increased the diffusion of crotoxin and PLA2
through mice tissues. The mice injected with crotoxin plus hyal-
uronidase exhibited spasm and motor difﬁculties 180 min after
subplantar injection. Two animals had died 330 min after injection,
and all animals in this group were dead the day after the test.
However, no animal injected with crotoxin, without the enzyme,
died. CdtHya1 acted as “spreading factor” of the toxin, increasing its
absorption rate by the tissues and causing greater damage to the
organism. It is worth to note that the animals of the other ﬁve
groups were normal throughout the test and the next day. So
hyaluronidase inhibition can contribute for minimizing local tissue
damage and the systemic distribution of venom as determined in
other studies [58]. Besides acting as a spreading factor, CdtHya1 has
antiedematogenic activity. Mice injected with crotoxin showed
almost 80% of oedema paw, while it was observed almost 40% of
oedema paw when CdtHya1 was associated to crotoxin, compared
to the control in 30 min. It also was effective in accelerating the
dispersion of buffer in the tissues. In 340 min, the paw thickness of
animals injected with hyaluronidase plus PLA2 returned to baseline
values, while in animals injected with crotoxin and crotoxin plus
hyaluronidase the oedema persisted. These results support theconviction that crotoxin complex is more toxic than pure PLA2, as
reported in the literature [59e61]. The antiedematogenic activity is
probably due to substrate hydrolysis, since hyaluronan possesses
strong water-binding capacity [24] and its massive accumulation
has been documented in oedema [62]. It was also reported that
hyaluronidase did not cause oedema formation and did not induce
an increase in lung vascular permeability, ameliorating pulmonary
ﬁbrosis by mesenchymal-like cells recruitment [63].
The sequence of the ﬁrst 44 amino acids of the N-terminal
region of CdtHya1 showed identity with those of other hyaluroni-
dase sequences previously deposited of other species of snakes
belonging to the same Viperidae family. These primary sequences
were aligned to determine the amino acid residues conserved
among these snake hyaluronidases. CdtHya1 shows a high
sequence identity with hyaluronidases obtained by transcriptome
from Bitis arietans, Cerastes cerastes, Echis pyramidum, Echis ocella-
tus, non-conservative substitutions being observed only in a few
positions. These snake hyaluronidases present a high level of
sequence identity (>95%) and retain all the catalytic, positional and
structural residues that characterize this class of enzyme [12]. The
signal peptides of these sequences were reported as being from
residues 1 to 20 [12]. However, alignment with CdtHya1, whose
sequence was obtained from the pure enzyme which is secreted by
the snake venom gland, suggests that residues 21e23 are also part
of the signal peptide.
The puriﬁcation, structural and biological characterization of
bioactive molecules lead to the development of new research tools,
diagnostic reagents and therapeutic drugs [64,65]. New biomole-
cules isolated from venomous animals present great potential for
medical applications [64e69] and theyare expected to beused in the
development of antivenoms. Though proved to be efﬁcient, the
systemically administered antivenoms have minimal protective
effect on local tissue necrosis. Therefore, hyaluronidases should be
considered as potential targets for a better snake bite treatment.
Inhibitors of locally acting hyaluronidases not only reduced local
tissuedamagebutalso reduced themagnitudeof systemiceffects [9].
In experimental studies, neutralization of hyaluronidase by mono-
clonal antibodies or derivatives fromplants inhibited tissue damage,
the diffusion and the lethal effects of ophidian venoms [9,15e17].
Although the amount of the enzyme in snake venoms is low,
hyaluronidases from venoms are very active, potentiate the toxicity
of the venom [4,8] and can cause systemic collapse of the victim
due to extensive degradation of hyaluronan [12]. Therefore, this
study on the characterization of hyaluronidase from C. d. terriﬁcus
snake venom may contribute to the optimization of therapies for
these accidents, and help in the understanding of the numerous
pathophysiological processes in which the enzyme is involved.
CdtHya1 also presented antiedematogenic activity. Thus, it could be
used therapeutically to reduce oedema.
5. Conclusions
In conclusion, despite the fact that the puriﬁcation procedure of
hyaluronidase CdtHya1 from C. d. terriﬁcus venom is relatively
simple, it was able to afford the ﬁrst rattlesnake hyaluronidase with
high antiedematogenic activity.
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